# EDGAR Filing Document

**Accession Number:** 0001620704
**File Stem:** 0001477932-25-005210
**Filing Date:** 2025-7
**Character Count:** 3102
**Document Hash:** eaecd6ba6b1506e3458383f416874855
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-25-005210.hdr.sgml**: 20250723

**ACCESSION NUMBER**: 0001477932-25-005210

**CONFORMED SUBMISSION TYPE**: 1-U

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250718

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20250723

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MED-X, INC.
- **CENTRAL INDEX KEY:** 0001620704
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 465473113
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 1-U
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 24R-00024
- **FILM NUMBER:** 251142852

**BUSINESS ADDRESS:**
- **STREET 1:** 8236 REMMET AVE.
- **CITY:** CANOGA PARK
- **STATE:** CA
- **ZIP:** 91304
- **BUSINESS PHONE:** (818) 349-2870

**MAIL ADDRESS:**
- **STREET 1:** 8236 REMMET AVE.
- **CITY:** CANOGA PARK
- **STATE:** CA
- **ZIP:** 91304

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 1-U**

**CURRENT REPORT PURSUANT TO REGULATION A**

Date of Report (Date of earliest event reported): July 18, 2025

---

| |
|:---|
| **MED-X, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Nevada** | **46-5473113** |
| State of other jurisdiction <br> of incorporation or organization | (I.R.S. Employer <br> Identification No.) |

---

**<u>8236 Remmet Avenue, Canoga Park, California 91304</u>**

(Full mailing address of principal executive offices)

**<u>(818) 349-2870</u>**

(Issuer's telephone number, including area code)

Title of each class of securities issued pursuant to Regulation A:

**Common Stock, par value $0.001 per share**

**Item 9. Other Events**

**Resignation of a Director and Appointment of a New Director**

On July 18, 2025 Med-X, Inc.'s ("Company") Board of Directors held a meeting and accepted the resignation of Dr. Morton Hyson as a Board of Directors Member effective as of June 28, 2025.

On July 18, 2025 Med-X, Inc.'s ("Company") Board of Directors held a meeting to appoint one new independent Director. The new Director is Mrs. Mary Kay Wilson, currently Owner/Principal Broker of Claremont Realty Group, LLC. In addition, Mrs. Wilson possesses Entrepreneurial leadership skills and who has built and sold a highly successful retail business.

*This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors.*

**SIGNATURES**

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **MED-X, INC.** |
|  | (Exact name of issuer as specified in its charter) |
| Date: July 23, 2025 |  |
|  | */s/ Ronald J. Tchorzewski* |
|  | Ronald J. Tchorzewski – Chief Financial Officer |

---